A. Carrillo-Muñoz

发表

In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast OneTM

J. Pemán, E. Cantón, G. Quindós, 2006, Mycoses.

Effect of Culture Medium on the Disk Diffusion Method for Determining Antifungal Susceptibilities of Dermatophytes

J. Guarro, I. Inza, B. Fernández-Torres, 2006, Antimicrobial Agents and Chemotherapy.

Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method.

G. Quindós, O. Del valle, J. Hernández-Molina, 2011, International journal of antimicrobial agents.

In vitro activity of voriconazole against Mexican oral yeast isolates

G. Quindós, A. Carrillo-Muñoz, J. Aguirre, 2010, Mycoses.

Activity of Caspofungin and Voriconazole against Clinical Isolates of Candida and Other Medically Important Yeasts by the CLSI M-44A Disk Diffusion Method with Neo-Sensitabs Tablets

G. Quindós, O. Del valle, P. Santos, 2007, Chemotherapy.

In vitro Susceptibility of Candida dubliniensis to Current and New Antifungal Agents

J. Pemán, E. Cantón, A. Valverde, 2000, Chemotherapy.

In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.

G. Quindós, A. Carrillo-Muñoz, M. Ruesga, 1999, The Journal of antimicrobial chemotherapy.

Combination antifungal therapy: a strategy for the management of invasive fungal infections.

N. Jauregizar, G. Quindós, A. Carrillo-Muñoz, 2014, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Biofilm formation by five species of Candida on three clinical materials.

A. Carrillo-Muñoz, D. Estivill, M. P. Arévalo, 2011, Journal of microbiological methods.

In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.

G. Quindós, A. Carrillo-Muñoz, S. Brena, 2004, Revista iberoamericana de micologia.

Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.

G. Quindós, J. Hernández-Molina, A. Carrillo-Muñoz, 2011, The Journal of antimicrobial chemotherapy.

Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies

A. Carrillo-Muñoz, G. Giusiano, M. Cattana, 2017, Mycoses.

Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients.

J. M. Torres-Rodríguez, G. Quindós, M. Rubio, 1999, Revista iberoamericana de micologia.

Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method.

A. Espinel-Ingroff, G. Quindós, A. Carrillo-Muñoz, 2003, The Journal of antimicrobial chemotherapy.

Collaborative Evaluation of Optimal Antifungal Susceptibility Testing Conditions for Dermatophytes

J. Guarro, I. Inza, B. Fernández-Torres, 2002, Journal of Clinical Microbiology.

Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.

J. Guarro, G. Quindós, J. Hernández-Molina, 2008, International Journal of Antimicrobial Agents.

In Vitro Antifungal Activity of Sertaconazole Against 309 Dermatophyte Clinical Isolates

J. Guarro, B. Fernández-Torres, A. Carrillo-Muñoz, 2003, Journal of chemotherapy.

[In vitro antifungal susceptibility profile of Scopulariopsis brevicaulis isolated from onychomycosis].

A. Carrillo-Muñoz, C. Tur-Tur, G. Giusiano, 2015, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.

J. Guarro, G. Quindós, O. Del valle, 2007, International journal of antimicrobial agents.

[Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?].

G. Quindós, O. Del valle, P. Santos, 2004, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species

A. Carrillo-Muñoz, C. Tur-Tur, G. Giusiano, 2013, Mycoses.

In Vitro Antifungal Activity of Sertaconazole Nitrate Against Recent Isolates of Onychomycosis Causative Agents

G. Quindós, O. Del valle, J. Hernández-Molina, 2008, Journal of chemotherapy.

Comparative study of the in vitro antifungal activity of bifonazole, naftifine and sertaconazole against yeasts.

A. Carrillo-Muñoz, C. Tur-Tur, F. Bornay-Llinares, 1999, Journal of chemotherapy.

Sertaconazole: updated review of a topical antifungal agent

G. Quindós, A. Carrillo-Muñoz, G. Giusiano, 2005, Expert review of anti-infective therapy.

Comparison of in vitro Antifungal Activities of Amphotericin B Lipid Complex with Itraconazole against 708 Clinical Yeast Isolates and Opportunistic Moulds Determined by National Committee for Clinical Laboratory Standards Methods M27-A and M38-P

J. Guarro, J. Pemán, E. Cantón, 2002, Chemotherapy.

In vitro Antifungal Activity of Sertaconazole Compared with Nine Other Drugs against 250 Clinical Isolates of Dermatophytes and Scopulariopsis brevicaulis

A. Guglietta, G. Quindós, O. Del valle, 2004, Chemotherapy.

[Antifungal agents for onychomycoses].

J. Hernández-Molina, P. Santos, A. Carrillo-Muñoz, 2010, Revista iberoamericana de micologia.

Sertaconazole Nitrate Shows Fungicidal and Fungistatic Activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, Causative Agents of Tinea Pedis

A. Carrillo-Muñoz, C. Tur-Tur, D. Estivill, 2011, Antimicrobial Agents and Chemotherapy.

Sertaconazole Antifungal Profile Determined by a Microdilution Method versus Nine Topical Substances against Dermatophyte Fungi

A. Carrillo-Muñoz, C. Tur-Tur, G. Giusiano, 2012, Chemotherapy.

[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].

G. Quindós, O. Del valle, A. Carrillo-Muñoz, 2005, Revista iberoamericana de micologia.

In Vitro Activities of New Triazole Antifungal Agents, Posaconazole and Voriconazole, Against Oral Candida Isolates from Patients Suffering from Denture Stomatitis

G. Quindós, A. Carrillo-Muñoz, C. Marcos-Arias, 2011, Mycopathologia.

Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.

G. Quindós, J. Hernández-Molina, P. Santos, 2010, Revista Espanola de Quimioterapia.

Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.

D. Loebenberg, G. Quindós, J. Hernández-Molina, 2005, The Journal of antimicrobial chemotherapy.

In Vitro Activity of a New Liposomal Nystatin Formulation Against Opportunistic Fungal Pathogens

G. Quindós, A. Carrillo-Muñoz, M. Ruesga, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].

J. Pemán, E. Cantón, G. Quindós, 2007, Revista Iberoamericana de Micologia.

Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis

N. Jauregizar, G. Quindós, A. Carrillo-Muñoz, 2013, Expert review of anti-infective therapy.

Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing.

G. Quindós, M. Rubio, J. Hernández-Molina, 1999, Revista iberoamericana de micologia.

Antifungal agents: mode of action in yeast cells.

G. Quindós, A. Carrillo-Muñoz, G. Giusiano, 2006, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Microdilution susceptibility for Candida, dermatophytes and moulds using flutrimazole and clotrimazole

J. M. Torres-Rodríguez, A. Carrillo-Muñoz, N. Madrenys-Brunet, 1994 .

Multicenter evaluation of ATB fungus: a standardized micromethod for yeast susceptibility testing.

J. M. Torres-Rodríguez, G. Quindós, A. Carrillo-Muñoz, 1994, Chemotherapy.

Fluconazole Susceptibilities of Bloodstream Candidasp. Isolates as Determined by National Committee for Clinical Laboratory Standards Method M27-A and Two Other Methods

J. Pemán, E. Cantón, Á. Viudes, 1999, Journal of Clinical Microbiology.

Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.

A. Espinel-Ingroff, G. Quindós, A. Carrillo-Muñoz, 2008, Revista iberoamericana de micologia.

[Colorimetric methods for in vitro antifungal susceptibility testing].

G. Quindós, A. Carrillo-Muñoz, L. Abarca, 2001, Revista iberoamericana de micologia.

Comparison of Tablet and Disk Diffusion Methods for Fluconazole and Voriconazole In Vitro Activity Testing Against Clinical Yeast Isolates

A. Rementeria, G. Quindós, A. Carrillo-Muñoz, 2007, Journal of chemotherapy.

Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates.

G. Quindós, O. Del valle, P. Santos, 2002, International journal of antimicrobial agents.

Sertaconazole: In-Vitro Antifungal Activity Against Vaginal and Other Superficial Yeast Isolates

A. Guglietta, A. Espinel-Ingroff, G. Quindós, 2001, Journal of chemotherapy.

[A new generation of antifungal drugs].

G. Quindós, A. Carrillo-Muñoz, G Quindós, 2001, Revista iberoamericana de micologia.

In-vitro antifungal activity of sertaconazole, econazole, and bifonazole against Candida spp.

J. M. Torres-Rodríguez, A. Carrillo-Muñoz, 1995, The Journal of antimicrobial chemotherapy.

Comparative in vitro Antifungal Activity of Amphotericin B Lipid Complex, Amphotericin B and Fluconazole

J. Pemán, G. Quindós, A. del Palacio, 2000, Chemotherapy.

Comparative evaluation of four commercial tests for presumptive identification of Candida albicans.

A. Carrillo-Muñoz, A. Sierra, M. P. Arévalo, 2004, Journal of microbiological methods.

Minimal inhibitory concentrations of sertaconazole, miconazole and clotrimazole against 14 strains of Scopulariopsis brevicaulis isolated from onychomycoses

J. M. Torres-Rodríguez, A. Carrillo-Muñoz, N. Madrenys-Brunet, 1993 .

[Tinea capitis: two years experience in a paediatric hospital of Buenos Aires, Argentina].

H. Lopardo, A. Carrillo-Muñoz, S. Córdoba, 2010, Revista iberoamericana de micologia.

Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts.

J. Pemán, José P. Martínez, E. Cantón, 2007, The Journal of antimicrobial chemotherapy.

[Epidemiology of fungaemia in a paediatric hospital of high complexity].

A. Carrillo-Muñoz, S. Córdoba, L. Rodero, 2010, Revista iberoamericana de micologia.

Comparative study on the survival of 5 species of dermatophytes and S. brevicaulis in beach sand, under laboratory conditions.

A. Carrillo-Muñoz, J. M. Rodríguez, N. Madrenys-Brunet, 1990 .

[Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].

M. Díaz, A. Carrillo-Muñoz, R. Camponovo, 2016, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

In Vitro Activities of New Triazole Antifungal Agents, Posaconazole and Voriconazole, Against Oral Candida Isolates from Patients Suffering from Denture Stomatitis

G. Quindós, A. Carrillo-Muñoz, C. Marcos-Arias, 2011, Mycopathologia.